Jul 16, 2020
Vertex Pharmaceuticals Selects TRIA to Design Laboratory and Office for New 268,000 SF VCGT Research Site
Jun 22, 2020
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Jun 18, 2020
Akebia Therapeutics Announces New Chief Financial Officer
Jun 08, 2020
Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal
May 20, 2020
Provention Bio Announces Changes to its Board of Directors
May 07, 2020
Akcea Expands Leadership Team with Appointment of Carla Poulson as Senior Vice President and Chief Human Resources Officer
Jan 06, 2020
New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime
Dec 18, 2019
Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO
Dec 06, 2019
Cystic Fibrosis Therapeutics Market to Garner $9.27 Bn, Globally, by 2026 at 9.2% CAGR, Says Allied Market Research
Nov 28, 2019
Global Cystic Fibrosis Drugs Market by Drug Class, Route of Application & Region - Forecast to 2025
Nov 07, 2019
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Oct 23, 2019
Global Nontuberculous Mycobacterial Infections Pipeline Report 2019: Therapeutic Candidates in Discovery and Preclinical, Phase 1, Phase 2, and Phase 3 Stage
Oct 21, 2019
FDA approves new breakthrough therapy for cystic fibrosis
Oct 21, 2019
CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
Jul 25, 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Jul 23, 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Jul 12, 2019
BNBuilders Implements Flawless Interior Design for Vertex Pharmaceuticals Building, Earning Calibre Design Award
Jun 21, 2019
FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
May 14, 2019
Global cystic fibrosis market is expected to grow with a CAGR of 16.6% over the forecast period from 2019-2025
Oct 17, 2018
Proteostasis Therapeutics Announces Positive Preliminary Results from Proprietary Doublet in Cystic Fibrosis Patients